Abstract
Introduction: Patients presenting with drooling frequently site a reduced quality of life secondary to both psychological and physical consequences. Botulinum toxin B (Neurobloc) has been provided as a treatment for drooling in a specialist clinic at St George's Hospital since 2000. The aim of this audit was to assess the effectiveness of Neurobloc in the treatment of drooling by way of a patient satisfaction survey.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
